Pyrrolidine-3-carboxamide hydrochloride, 95.0%, 5g

(S)-3-((tert-Butoxycarbonyl)amino)-3-(m-tolyl)propanoic acid, 95.0%, 1g

3-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide, 97.0%, 250mg

di-Sodium hydrogen phosphate, 500 g

Ambroxol Hydrochloride, 97.0%, 500g

1-BOC-3-FLUORO-3-AZETIDINEACETIC ACID, 95.0%, 250mg

1-(2-Amino-acetyl)piperidine-3-carboxylic acidethylester hydrochloride, 98.0%, 10g

tert-Butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroisoquinoline-2(1H)-carboxylate, 95.0%, 5g

3-Aminophthalic Acid>95.0%(T)5g

7-Chloroimidazo[1,2-b]pyridazine, 95.0%, 50mg

3-(4-Heptyloxybenzoyl)-4-methylpyridine, 97.0%, 1g

(5-(2-((tert-Butyldimethylsilyl)oxy)ethyl)-2-chlorophenyl)methanol, 98%, 100mg

Microliter syringe GASTIGHT® series 1000, 5.0 ml, 1005 TLL, 1 piece